Endoscopic Vessel Harvesting Systems Market Is Expected To Grow At A CAGR Of 6.1% From 2017 To 2025

Global Endoscopic Vessel Harvesting Systems Market is expected to reach USD 3.4 billion by 2025, according to a new report by Grand View Research, Inc. Growing inclination of the patient population toward minimally invasive cardiac surgeries is one of the key factors expected to drive the market in the coming few years.

The introduction of endoscopic vessel harvesting technology in the field of cardiac surgery was a significant milestone in 1996. According to estimates by the Texas Heart Institute, every year over 200,000 procedures were performed in the U.S. Also, based on the statistics published by the department of surgery (Washington University School of Medicine in St. Louis), they perform Coronary Artery Bypass Grafting (CABG) surgeries on approximately 0.5 million people very year. The growing demand for these procedures and technologically advanced surgical procedures are among few factors anticipated to boost the market over the forecast period.

The presence of favorable reimbursement policies in the U.S. pertaining to CABG surgeries is anticipated to increase the number these surgeries. On July 2016, the Department of Health & Human Services announced that it will begin implementing bundled payment models for high-quality, coordinated cardiac and hip fracture care. The market is highly concentrated with a limited number of products and market players operating in this space. Many studies stated that the open vessels harvesting technique is as effective as minimally invasive vessels harvesting technique. However, the growing awareness regarding benefits of Endoscopic Vessels Harvesting (EVH), such as minimally invasive nature, less complications, and quick recuperation are some of the factors that are anticipated to propel its growth during the forecast period.

Full research report on Global Endoscopic Vessel Harvesting Systems Market Analysis:
http://www.grandviewresearch.com/industry-analysis/endoscopic-vessel-harvesting-system-market

Further Key Findings From the Report Suggest:

• The global endoscopic vessel harvesting system market size was estimated at USD 1,881.7 million in 2016 and is expected to grow at a CAGR of 6.1% from 2017 to 2025
• Reusable EVH systems emerged as the largest product segment in 2015 and is estimated to generate revenue over USD 2,136.0 million by 2025
• Global disposable EVH systems was USD 639.3 million in 2016 and is anticipated to witness fastest growth over the next 8 years
• The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies in the region. The regional market is expected to grow at a CAGR of 7.7% from 2017 to 2025
• Some of the key players including MAQUET Holding B.V. & Co. KG; CARDIO MEDICAL GmbH; Terumo Cardiovascular Group; Med Europe S.r.l. (Elite Life Care); LivaNova plc. (Sorin and Cyberonics); and Saphena Medical, Inc. dominated the global endoscopic vessels harvesting systems market.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Endoscopic Vessel Harvesting Systems Market on the basis of product and region:

Endoscopic Vessel Harvesting SystemProduct Outlook (Revenue, USD Million, 2014 - 2025)

• Disposable
• Reusable

Endoscopic Vessel Harvesting SystemRegional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-endoscopic-vessel-harvesting-system-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Hepatitis Therapeutics Market Size Is Anticipated To Reach $25.8 Billion By 2025

Global Hepatitis Therapeutics Market is expected to reach USD 25.8 billion by 2025 according to a new report by Grand View Research, Inc. The key factors driving market growth include the rising number of infected population, growing consumption of alcohol & drugs, increase in global geriatric population, and improvement in access to hepatitis medicines.

Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic hepatitis. The population at a greater risk of hepatitis include people with HIV infection & HCV-infected sexual partners, who inject drugs & use intranasal drugs, recipients of infected blood products, and other population groups who live in unhygienic conditions.

According to the WHO, globally around 400 million people are infected with at least one form of hepatitis and every year nearly 1.4 people die due to the condition. Various government and private agencies are actively involved in the vaccination drive to prevent hepatitis. Hepatitis C leads to more serious complications compared to hepatitis A and B. As per WHO estimates, nearly 150 million are impacted by hepatitis C infection globally. Moreover, a significant number of hepatitis C patients develop liver cancer or liver cirrhosis and nearly 700,000 people die due to hepatitis C infection & associated conditions.

Access Full Research Report on Global Hepatitis Therapeutics Market:
http://www.grandviewresearch.com/industry-analysis/hepatitis-therapeutics-market

Further Key Findings From the Report Suggest:

• Due to very high prevalence of target disease coupled with subsequent increase in the treatment rate Hepatitis C accounted for the majority market share of 75.6% in 2016
• In 2016, North America held the largest share of nearly 42.9%. The key factors attributed to the regions high share include high patient awareness levels and the presence of advanced healthcare infrastructure. 
• Asia Pacific is anticipated to witness the maximum growth with a CAGR of 5.8% over the forecast period. High economic development coupled with rapidly increasing healthcare expenditure are amongst key factors attributing to the regions high growth rate.
• Key players include Gilead, Merck & Co. Inc., Johnson & Johnson, Bristol-Myers Squibb Company, and AbbVie Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Hepatitis Therapeutics Market on the disease type, and region:

Hepatitis Therapeutics Disease Type Outlook (Revenue, USD Million, 2014 - 2025)

• Hepatitis A
• Hepatitis B
• Hepatitis C
• Others

Hepatitis Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

View Press Release On Global Hepatitis Therapeutics Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-computer-aided-engineering-cae-market   

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Cardiovascular Information System (CVIS) Market Is Segmented On The Basis Of System Type, Mode Of Operation, And Geography 2013-2024

Global Cardiovascular Information System (CVIS) Market is expected to reach USD 1.2 billion by 2024, according to a new report by Grand View Research Inc. The global cardiovascular devices industry is growing swiftly owing to the increasing prevalence of heart diseases and other cardiovascular problems. 

In accordance with the growing patient population there is an exponential surge in the patient history documents and patient data records. The resultant, rising burden of patient data is pushing forward the demand for effective management tools; thus, offering increased accessibility of patient information to surgeons and the healthcare staff and hence enhancing the operational efficiency of the practices. In addition, factors, such as technological advancements and the gradually growing awareness regarding the availability of these improved systems are expected to fuel the growth of the cardiovascular devices market. 

However, factors, such as high system costs and the lack of skilled operators are impeding the overall growth. In addition, the presence of alternative data management tools is challenging the adoption of the information systems specific to cardiovascular data management. Some of the key players in the market are implementing strategies to expand market share. For instance, companies, such as Philips Healthcare and GE Healthcare offer CVIS systems along with their cardiac imaging products.  

Access Full Research Report on Global Cardiovascular Information System Market: http://www.grandviewresearch.com/industry-analysis/cardiovascular-information-system-market

Further key findings from the study suggest:

• The CVIS segment captured the largest market share of the global market in 2015. Integration of these systems with imaging devices is responsible for the highest adoption rate of this segment.
• Owing to the high cost of these systems, the CVIS segment is expected to maintain its dominance during the forecast period
• The cloud-based segment is anticipated to exhibit the fastest growth rate during the forecast period. The associated advantages, such as the affordable cost, remote accessibility of data, and the user friendly interface, are expected to fuel the adoption of the cloud-based mode of operation.
• North America capturedthe largest market share of around 36% in 2015. The dominance of the segment is expected to continue with a CAGR of 5.8% from 2016 to 2024.
• The factors contributing to the growth of the North America market include the increasing prevalence of heart diseases and the technological advancements in the region. Moreover, factors, such as the availability of highly advanced healthcare facilities and the higher adoption rate of the data management tools are augmenting the market growth in North America.
• Asia Pacific is anticipated to grow at the fastest rate during the forecast period. Countries, such as India and China are expected to be the fastest growing markets in the region owing to the large pool of cardiovascular patients and the rising healthcare expenditure.
• The booming medical tourism in Asia Pacific due to the availability of advanced healthcare facilities and services at a lower cost in comparison to the other developed countries serves as the pivotal factor in attracting cardiac patients worldwide to this region.
• Some major players in this market include Philips Healthcare, GE Healthcare, McKesson Corporation, Siemens Healthcare GmbH, Merge Healthcare, Inc., Agfa Healthcare N.V., Cerner Corporation, Fujifilm Medical Systems, Inc., Lumedx Corporation, and Digisonics, Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global Cardiovascular Information System (CVIS) Market on the basis of system type, mode of operation, and geography.

Cardiovascular information system (CVIS) market, by system, 2013 - 2024 (USD Million)

• CVIS
• CPACS 

Cardiovascular information system (CVIS) market, by mode of operation, 2013 - 2024 (USD Million)

• Web-based
• On-site
• Cloud-based 

Cardiovascular information system (CVIS) market, by region, 2013 - 2024 (USD Million)

• North America
• U.S. Cardiovascular Information System, by Systems
• Canada Cardiovascular Information System, by Systems
• U.S. Cardiovascular Information System, by Mode of Operation
• Canada Cardiovascular Information System, by Mode of Operation
• Europe
• U.K. Cardiovascular Information System, by Systems
• Germany Cardiovascular Information System, by Systems
• U.K. Cardiovascular Information System, by Mode of Operation
• Germany Cardiovascular Information System, by Mode of Operation
• Asia Pacific
• China Cardiovascular Information System, by Systems
• India Cardiovascular Information System, by Systems
• China Cardiovascular Information System, by Mode of Operation
• India Cardiovascular Information System, by Mode of Operation
• Latin America
• Brazil Cardiovascular Information System, by Systems
• Mexico Cardiovascular Information System, by Systems
• Brazil Cardiovascular Information System, by Mode of Operation
• Mexico Cardiovascular Information System, by Mode of Operation
• MEA
• South Africa Cardiovascular Information System, by Systems
• South Africa Cardiovascular Information System, by Mode of Operation

View Press Release On Global Cardiovascular Information System (CVIS) Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-cardiovascular-information-system-cvis-market        

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Cardiac Prosthetic Device Market Is Segmented On The Basis Of Product 2014-2025

Global Cardiac Prosthetic Device Market is expected to be over USD 8.7 billion by 2025, based on a new study by Grand View Research, Inc. Rising demand for minimally invasive devices has provided greater growth prospects for the market. New product development through technological advancements is anticipated to foster market growth. The major companies are focusing on expanding their product life and safety benefits of the cardiac prosthetic devices. Such initiatives undertaken by the key players have resulted in increasing survival rates and low stroke rates for transcatheter aortic valves.

Transcatheter Aortic Valve Replacement (TAVR) is covered by Evidence Development (CED) Coverage provided by the Centers for Medicare & Medicaid Services (CMS). Cardiac pacemakers are also covered under Medicare program. Initiatives for reimbursement from the government for such devices are anticipated to boost the demand for cardiac prosthetic devices.

Access Full Research Report on Global Cardiac Prosthetic Device Market:
http://www.grandviewresearch.com/industry-analysis/cardiac-prosthetic-devices-market

Further Key Findings From the Study Suggest:

• Heart valve segment was one of the largest segments in 2015 owing to rising prevalence of valvular disease and heart valve failure.
• Pacemakers segment is expected to grow significantly, owing to rising reimbursement policies for pacemaker-related surgeries.
• Mechanical heart valve segment contributed toward the one of the largest market share in 2015 owing to its increasing product longevity. Moreover, they provide better hemodynamic efficiency. Since mechanical valves are made up of strong durable materials, such as titanium and carbon, they are preferred over other cardiac prosthetic devices.
• Transcatheter valve is expected to exhibit lucrative CAGR over the forecast period. TAVR has shown improved patient survival rate as compared to medical therapy. In the past years, it has evolved as a minimally invasive alternative treatment for surgical valve replacement.
• Implantable pacemakers are one of the highest revenue generating segments owing to their greater applicability pertaining to heart failure (HF) and other cardiovascular diseases like stroke.
• North America contributed toward the largest market share of around 40.0% in 2015. This is primarily due to the fact that the number of pacemaker implantations has increased amongst the Americans over the past two decades. Moreover, companies are focusing on commercial availability of technologically advanced devices in the U.S.
• Asia Pacific is anticipated to witness highest CAGR over the forecast period owing to the growing geriatric population in Japan. In 2015, the geriatric population base accounted for around 27% in Japan.
• Some key companies in this market are Medtronic, Inc.; St. Jude Medical, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Abbott Vascular; Siemens Healthcare GmbH; and Sorin Group.
• New product development through introduction of advanced technology and mergers & acquisitions are some of the key strategies adopted by the companies to enhance the demand for cardiac prosthetic devices. For instance, in 2015, St. Jude Medical and Thoratec, a company that specializes in mechanical circulatory support technology for the treatment of advanced HF, entered into a definitive agreement aiming at acquisition of the outstanding shares of Thoratec.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Cardiac Prosthetic Device Market on the basis of product:

Cardiac prosthetic device market Product Outlook (Market Revenue in USD Million, 2014 - 2025)

• Heart valves

·         Mechanical valve

·         Tissue valve

§  Stented tissue valve

§  Stentless tissue valve

·         Transcatheter valve

·         Pacemakers

·         Implantable pacemakers

§  Single-Chamber Battery Pacemaker

§  Dual-Chamber Battery Pacemaker

§  Triple-Chamber Battery Pacemaker

·         External pacemakers

Cardiac prosthetic device market Regional Outlook (Market Revenue in USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa
• South Africa

View Press Release On Global Agricultural Robots Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-cardiac-prosthetic-devices-market       

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Cardiac Biomarkers Market Is Segmented On The Basis Of Type, Application, End Use, And Region 2013-2024

Cardiac Biomarkers Market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth during the forecast period from 2016 to 2024. Analysis of global market trends focuses on the increasing demand for cardiac biomarkers owing to its increased adoption in cardiovascular disease diagnosis. Furthermore, this growth is attributed to a majority of factors, such as the high prevalence of Acute Coronary Syndrome (ACS), continual technological advancements in the development of cardiovascular biomarkers, increasing number of new product launches by the key market players, rising demand for point of care cardiac testing kits, along with the high specificity and sensitivity of these biomarkers in the detection of cardiovascular diseases, especially acute myocardial infarction.

The cardiac biomarkers market has been classified by type into troponin, Creatine kinase-MB(CK-MB), B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP), myoglobin, and others. Troponin is a heteromeric protein and comprises cardiac troponin T & I, which are abbreviated as cTnT & cTnI, respectively. The troponin biomarkers segment is expected to grow lucratively in the forecast period at a significant CAGR. The diagnostic efficiency and specificity related to cardiac biomarker testing renders it a universally gold standard test to diagnose cardiovascular disorders worldwide. The market by application is segmented into acute coronary syndrome, myocardial infarction, congestive heart failure, and others. ACS is expected to be the highest grossing segment according to the study. ACS is responsible for huge medical costs globally and is responsible for most hospital readmission cases. The increasing efforts to cut down worldwide ACS prevalence rates are expected to drive the growth of the biomarkers market.

The key countries included in the report are U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa, and the Middle East. North America accounted for the largest market in 2015, whereas the Asia Pacific region is anticipated to be the fastest growing region during the forecast period.

Full Research Report on Global Cardiac Bio-makers Market:
http://www.grandviewresearch.com/industry-analysis/cardiac-biomarker-market

Further key findings from the study suggest:

• North America is estimated to dominate the global cardiac biomarkers market. The high prevalence of coronary heart disease in western countries is one of the major factors contributing to the high demand for cardiac biomarker diagnostics.
• The Asia Pacific region is anticipated to be the fastest growing region in the study period owing to the large population, especially in China and India. Apart from that, there exists a high prevalence rate of myocardial infarction in the region. This prevalence rate is expected to fuel the demand for cardiac biomarker diagnostics.
• The troponin biomarker segment is expected to grow at a significant rate, and is expected to grow at the highest CAGR compared to others and accounts for the largest market share in 2015.
• The sector comprises of several local as well as global players. Some of the major players of this vertical include Alere, Inc., Siemens Healthcare GmbH, Roche Diagnostics, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and bioMerieux SA.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the Global Cardiac Biomarkers Market on the basis of type, application, end use, and region:

Cardiac Biomarkers Type Outlook (Revenue, USD Million, 2013 - 2024)

• Troponin
• CK-MB
• Natriuretic peptides - BNP and NT-proBNP
• Myoglobin
• Others

Cardiac Biomarkers Market Application Outlook (Revenue, USD Million, 2013 - 2024)

• Acute Coronary Syndrome
• Myocardial infarction
• Congestive heart failure
• Others

Cardiac Biomarkers Market End-use Outlook (Revenue, USD Million, 2013 - 2024)

• Laboratory Testing
• Point of Care Testing

Cardiac Biomarkers Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
• Middle East

View Press Release On Global Agricultural Robots Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-cardiac-biomarker-market      

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Agricultural Robots Market Is Expected to Growing at a CAGR of 24.7% by 2025

Global Agricultural Robot Market is anticipated to reach USD 8.82 billion by 2025, according to a new report by Grand View Research, Inc. The agriculture industry is changing dramatically, across the globe. The growing technological advancements and innovations in robotics have increased the sales of the agricultural robots.

Indoor farming refers to crop cultivation using high-pressure sodium lamps or LEDs and growth in aeroponic and hydroponic systems. Additionally, indoor farming provides protection and optimal growing conditions. The use of this technology by small commercial growers for producing crops is expected to increase their capacity and economic viability.

The future of the indoor farming industry is technology and data driven. The climate control technology is enabling high yields. A farm management system helps growers in reducing the time spent on analyzing and collecting crop yield data. The growing adoption of indoor farming is likely to spur the agriculture robot market.

Farm employment includes exposure to pesticides, long working hours, poor sanitary conditions, and other health risks. Most of the agricultural work is physical in nature, which increases the risks of accidents by fatigue, difficult terrain, poorly designed tools, and extreme weather conditions. In addition to physically demanding labor, heat & sun exposure and dangerous machinery increase the risks of farming.

Based on working methods, the working conditions in commercial plantations vary from traditional intensive methods to highly mechanized extensive methods. However, only some of the agricultural workers are covered by employment injury benefits, national legislation, and insurance schemes.

Farming causes several respiratory hazards in farmworkers. Organic dust toxic syndrome (ODTS), caused by grain and silage dust, is a common respiratory illness prevailing among the farmers. Agricultural noise and chemical hazards are the other common health hazards of farming. Prolonged exposure to excessive noise produced by choppers, tractors, chainsaws, and grain dryers can cause permanent hearing loss.

However, lack of awareness and high initial capital investments are anticipated to restrain the market growth over the forecast period. The robots used for agricultural purposes require additional application-specific advanced processing equipment, resulting in increased capital investment.

Access Full Research Report on Global Agricultural Robots Market:
http://www.grandviewresearch.com/industry-analysis/agricultural-robots-market

Further key findings from the report suggest:

• Increasing privatization of agricultural resources and services are expected to drive the market demand
• Milking robots product segment is anticipated to dominate the market in terms of revenue over the projected period
• The growing penetration of vertical farming is likely to spur the materials management product segment
• The ability of drones to hover low over fields along with sensing devices has benefitted the farmers by reducing their dependability on climate
• The Asia Pacific region is witnessing highest penetration growth in the agricultural robot market and possesses greater growth opportunities for companies planning to invest in long haul
• The Chinese agricultural processes have been modernized by the introduction of the crop-dusting drones
• The key players of the agricultural robot market include CNH Industrial (UK), CLAAS (Germany), GEA Group (Germany), and Harvest Automation, Inc. (U.S.)

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the Global Agricultural Robot Market based on product, application, and region:

Agricultural Robot Product Outlook (Revenue, USD Million, 2014 - 2025)

• UAV
• Driverless tractor
• Milking robots
• Materials management

Agricultural Robot Application Outlook (Revenue, USD Million, 2014 -2025)

• Field farming
• Dairy management
• Animal management
• Soil management
• Crop management

Agricultural Robot Regional Outlook (Revenue, USD Million, 2014 -2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Asia Pacific
• China
• Japan
• India
• South America
• Mexico
• The Middle East and Africa (MEA)

View Press Release On Global Agricultural Robots Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-agricultural-robots-market     

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Nanoparticles Metal And Metal Oxides Market Is Segmented On The Basis Of Type, Application, And Region 2013-2025

Global Nanoparticles - Metal And Metal Oxides Market In Healthcare is anticipated to reach USD 80.74 billion by 2025, according to a new report by Grand View Research, Inc. Several nanotechnologies based medicines have been put forward for approval by the FDA which is anticipated to propel growth.

Success of nano-medicine has prompted the development of enhanced nanomaterials for clinical applications with particular emphasis in therapy and diagnostics. This has resulted into the significant production of metal oxide particles that hold potential utility in human medicine.

Remarkable evolution has been made in nanoparticle based medicines for theranostic applications in disease management. Diverse metals have been used for development of medicines with a promise to optimize the efficacy of nano-medicines and to improve the current standard of medical and clinical practices.

These particles are recognized to have major applications in drug delivery, diagnostic products, biomarker discovery, and product packaging. Widespread application spectrum of these particles in maintaining human health is expected to dramatically impact the progress of this market in the coming years.

Moreover, metal oxides are observed to have significant role in cancer treatment. Nanoparticle-augmented systems enable high-concentration targeted drug delivery to cancer cells, which in turn, is expected to enhance the usage rate of metal nanoparticles for cancer treatment. Development of drug delivery strategies using nanoparticle approaches are expected to bring about changes effective for cancer treatment.

However, prolonged exposure of nanoparticles adversely affects the human health as well environment thereby restraining their adoption rate. These products are involved in autophagy, oxidative stress, lysosome dysfunction, and the activation of certain signaling pathways, thereby exhibiting toxicity for human health.

Access Full Research Report on Global Nanoparticles - Metal And Metal Oxides in Healthcare Market: http://www.grandviewresearch.com/industry-analysis/nanoparticles-metal-oxides-in-healthcare-market

Further key findings from the report suggest:

• Presence of untapped potential in alumina and alumina oxide particles is anticipated to create immense opportunities
• Aluminum oxide in combination with polymeric membranes is studied for enhancement of drug delivery owing to its high porosity property displayed in the membranes
• This enhanced efficacy of the membrane performance by the addition of alumina nanoparticles to polymeric membranes is projected to increase its adoption
• Approval of various nanoparticle composition and surface properties for clinical diagnostics and treatment of viral infections is anticipated drive market demand
• In-vivo imaging dominated the market with respect to revenue share
• Use of antibody conjugated to Au nanorods Raman spectrum with polarized, sharpened, and enhanced results can be attributed for larger revenue share
• Oncology dominated over a decade and is projected to sustain its share over the forecast period.
• Rising incidence of cancer and other chronic multi-drug resistant diseases pronounces the demand for these particles.
• Aforementioned factor is anticipated to drive targeted delivery with fastest YoY growth
• Asia Pacific is projected to showcase lucrative progress in the coming years
• Key countries in the region are working to enhance the patient’s reach to nanotechnology-based solutions
• Moreover, continuous support from the government bodies pertaining to initiation of new projects is expected to play crucial role for projected CAGR
• Key players contributing in this market are Pfizer Inc., Brigham Women's Hospital (BWH), Immunolight LLC, nanoComposix, Nanobiotix, Nanospectra Biosciences, Inc, Merck KGaA, and AstraZeneca
• These participants are investing in development of the product portfolio that can target the chronic disorders
• Arrowhead Pharmaceuticals, Cytimmune Sciences, Inc, Nanobiotix, Celgene Corporation, Siteman Center of Cancer Nanotechnology Excellence (Washington University CCNE), and BIND Biosciences are few companies that have products in the pipeline phase

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Nanoparticles - Metal And Metal Oxides in Healthcare Market on the basis of type, application, and region:

Nanoparticles - Metal & Metal Oxides Type Outlook (Revenue, USD Billion, 2013 - 2025)

• Gold Nanoparticles
• Silver Nanoparticles
• Iron Oxide Nanoparticles
• Alumina Nanoparticles
• Gadolinium Oxide Nanoparticles
• Others

Nanoparticles - Metal & Metal Oxides Application Outlook (Revenue, USD Billion, 2013 - 2025)

• In-vivo Imaging
• Targeted Drug Delivery
• Proton Therapy
• In-vitro Assays
• Cell & Phantom Imaging

Nanoparticles - Metal & Metal Oxides Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa (MEA)
• South Africa

View Press Release On Global Nanoparticles - Metal And Metal Oxides in Healthcare Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-nanoparticles-metal-oxides-in-healthcare-market    

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com